Free Circulating ICAM-1 in Serum and Cerebrospinal Fluid of HIV-1 Infected Patients Correlate with TNF-α and Blood-brain Barrier Damage

7Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The mechanism for the initiation of blood-brain barrier damage and intrathecal inflammation in patients infected with the human immunodeficiency virus (HIV) is poorly understood. We have recently reported that tumour necrosis factor-α (TNF-α) mediates active neural inflammation and blood-brain barrier damage in HIV-1 infection. Stimulation of endothelial cells by TNF-α induces the expression of intercellular adhesion molecule-1 (ICAM-1), which is an important early marker of immune activation and response. We report herein for the first time the detection of high levels of free circulating ICAM-1 in serum and cerebrospinal fluid of patients with HIV-1 infection. Free circulating ICAM-1 in these patients correlated with TNF-α concentrations and with the degree of blood-brain barrier damage and were detected predominantly in patients with neurologic involvement. These findings have important implications for the understanding and investigation of the intrathecal inflammatory response in HIV-1 infection. © 1992, Rapid Communications of Oxford Ltd.

Cite

CITATION STYLE

APA

Sharief, M. K., Ciardi, M., Thompson, E. J., Noori, M. A., Salotti, A., Sorice, F., … Cirelli, A. (1992). Free Circulating ICAM-1 in Serum and Cerebrospinal Fluid of HIV-1 Infected Patients Correlate with TNF-α and Blood-brain Barrier Damage. Mediators of Inflammation, 1(5), 323–328. https://doi.org/10.1155/S0962935192000486

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free